Heyde Syndrome Complicated by a Dieulafoy Lesion

REFERENCES

1. 1.↵
   1. Natorska J,
   2. Mazur P,
   3. Undas A

   . Increased bleeding risk in patients with aortic valvular stenosis: from new mechanisms to new therapies. Thromb Res. 2016 Mar;139:85-89. doi: 10.1016/j.thromres.2016.01.016.

   OpenUrlCrossRef
2. 2.↵
   1. Heyde EC

   . Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 1958;259:196.

   OpenUrl
3. 3.↵
   1. Desai R,
   2. Parekh T,
   3. Singh S,
   4. et al.

   Alarming increasing trends in hospitalizations and mortality with Heyde's syndrome: a nationwide inpatient perspective (2007 to 2014). Am J Cardiol. 2019 Apr 1;123(7):1149-1155. doi: 10.1016/j.amjcard.2018.12.043.

   OpenUrlCrossRef
4. 4.↵
   1. Batouli A,
   2. Kazemi A,
   3. Hartman MS,
   4. Heller MT,
   5. Midian R,
   6. Lupetin AR

   . Dieulafoy lesion: CT diagnosis of this lesser-known cause of gastrointestinal bleeding. Clin Radiol. 2015 Jun;70(6):661-666. doi: 10.1016/j.crad.2015.02.005.

   OpenUrlCrossRef
5. 5.↵
   1. Gallard T

   . Aneurysmes milliares de l'estomac, donnant lieu a des hematemeses mortelles. Bull Mem Soc Med Hop Paris. 1884;1:84-91.

   OpenUrl
6. 6.↵
   1. Dieulafoy G

   . Exulceratio simplex. L'intervebtion chirurgicale dans les hematemeses foudroyantes consecutives a l'exulceration simple de l'estomac. Bull de L'Acad de Med. 1898;39:49-84.

   OpenUrl
7. 7.↵
   1. Frank W

   . Hematemesis associated with gastric arteriosclerosis. Gastroenterology. 1946 Aug;7:231-240.

   OpenUrl
8. 8.↵
   1. Donaldson GA,
   2. Hamlin E Jr.

   . Massive hematemesis resulting from rupture of a gastric-artery aneurysm; report of 3 cases. N Engl J Med. 1950 Sep 7;243(10):369-373. doi: 10.1056/NEJM195009072431003.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Baxter M,
   2. Aly EH

   . Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010 Oct;92(7):548-554. doi: 10.1308/003588410X12699663905311.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Randi AM,
    2. Laffan MA,
    3. Starke RD

    . Von Willebrand factor, angiodysplasia and angiogenesis. Mediterr J Hematol Infect Dis. 2013 Sep 2;5(1):e2013060. doi: 10.4084/MJHID.2013.060.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Turner NA,
    2. Nolasco L,
    3. Ruggeri ZM,
    4. Moake JL

    . Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. Blood. 2009 Dec 3;114(24):5102-5111. doi: 10.1182/blood-2009-07-231597.

    OpenUrlAbstract/FREE Full Text
12. 12.
    1. Tsai HM,
    2. Sussman II,
    3. Nagel RL

    . Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994 Apr 15;83(8):2171-2179.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Dent JA,
    2. Berkowitz SD,
    3. Ware J,
    4. Kasper CK,
    5. Ruggeri ZM

    . Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6306-6310. doi: 10.1073/pnas.87.16.6306.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Goto S,
    2. Ikeda Y,
    3. Saldívar E,
    4. Ruggeri ZM

    . Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest. 1998 Jan 15;101(2):479-486. doi: 10.1172/JCI973.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.
    1. Goto S,
    2. Salomon DR,
    3. Ikeda Y,
    4. Ruggeri ZM

    . Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem. 1995 Oct 6;270(40):23352-23361. doi: 10.1074/jbc.270.40.23352.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Peterson DM,
    2. Stathopoulos NA,
    3. Giorgio TD,
    4. Hellums JD,
    5. Moake JL

    . Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987 Feb;69(2):625-628.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Starke RD,
    2. Ferraro F,
    3. Paschalaki KE,
    4. et al.

    Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011 Jan 20;117(3):1071-1080. doi: 10.1182/blood-2010-01-264507.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Olsson AK,
    2. Dimberg A,
    3. Kreuger J,
    4. Claesson-Welsh L

    . VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006 May;7(5):359-371. doi: 10.1038/nrm1911.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Springer ML,
    2. Chen AS,
    3. Kraft PE,
    4. Bednarski M,
    5. Blau HM

    . VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell. 1998 Nov;2(5):549-558. doi: 10.1016/s1097-2765(00)80154-9.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Schwarz ER,
    2. Speakman MT,
    3. Patterson M,
    4. et al.

    Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation. J Am Coll Cardiol. 2000 Apr;35(5):1323-1330. doi: 10.1016/s0735-1097(00)00522-2.

    OpenUrlFREE Full Text
21. 21.↵
    1. Eklund L,
    2. Olsen BR

    . Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006 Mar 10;312(5):630-641. doi: 10.1016/j.yexcr.2005.09.002.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Fukuhara S,
    2. Sako K,
    3. Minami T,
    4. et al.

    Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol. 2008 May;10(5):513-526. doi: 10.1038/ncb1714.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Daly C,
    2. Pasnikowski E,
    3. Burova E,
    4. et al.

    Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15491-15496. doi: 10.1073/pnas.0607538103.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Daly C,
    2. Eichten A,
    3. Castanaro C,
    4. et al.

    Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition. Cancer Res. 2013 Jan 1;73(1):108-118. doi: 10.1158/0008-5472.CAN-12-2064.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Lazarus A,
    2. Keshet E

    . Vascular endothelial growth factor and vascular homeostasis. Proc Am Thorac Soc. 2011 Nov;8(6):508-511.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Somanath PR,
    2. Malinin NL,
    3. Byzova TV

    . Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis. 2009;12(2):177-185. doi: 10.1007/s10456-009-9141-9.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Randi AM,
    2. Smith KE,
    3. Castaman G

    . von Willebrand factor regulation of blood vessel formation. Blood. 2018 Jul 12;132(2):132-140. doi: 10.1182/blood-2018-01-769018.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Starke RD,
    2. Paschalaki KE,
    3. Dyer CEF,
    4. et al.

    Defective angiopoietin-2 release from von Willebrand disease patients’ blood outgrowth endothelial cells. J Thromb Haemost. 2013;11:175.

    OpenUrl
29. 29.↵
    1. Markowska AI,
    2. Liu F-T,
    3. Panjwani N

    . Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med. 2010 Aug 30;207(9):1981-1993. doi: 10.1084/jem.20090121.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Saint-Lu N,
    2. Oortwijn BD,
    3. Pegon JN,
    4. et al.

    Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor. Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):894-901. doi: 10.1161/ATVBAHA.111.240309.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Harrison SA,
    2. Marri SR,
    3. Chalasani N,
    4. et al.

    Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1183-1198. doi: 10.1111/apt.13816.

    OpenUrlCrossRef
32. 32.↵
    1. McKean SC,
    2. Ross JJ,
    3. Dressler DD,
    4. Scheurer DB

    1. Rotman SR,
    2. Saltzman JR

    . Upper gastrointestinal bleeding. In: McKean SC, , Ross JJ, , Dressler DD, , Scheurer DB, eds. Principles and Practice of Hospital Medicine. 2nd ed. New York, NY: McGraw-Hill Education; 2017.
33. 33.↵
    1. Chaer RA,
    2. Helton WS

    . Dieulafoy's disease. J Am Coll Surg. 2003 Feb;196(2):290-296. doi: 10.1016/S1072-7515(02)01801-X.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Rossi NP,
    2. Green EW,
    3. Pike JD

    . Massive bleeding of the upper-gastrointestinal tract due to Dieulafoy's erosion. Arch Surg. 1968 Nov;97(5):797-800. doi: 10.1001/archsurg.1968.01340050137021.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Juler GL,
    2. Labitzke HG,
    3. Lamb R,
    4. Allen R

    . The pathogenesis of Dieulafoy's gastric erosion. Am J Gastroenterol. 1984 Mar;79(3):195-200.

    OpenUrlPubMed
36. 36.↵
    1. Veldhuyzen van Zanten SJ,
    2. Bartelsman JF,
    3. Schipper ME,
    4. Tytgat GN

    . Recurrent massive haematemesis from Dieulafoy vascular malformation–a review of 101 cases. Gut. 1986 Feb;27(2):213-222. doi: 10.1136/gut.27.2.213.

    OpenUrlFREE Full Text
37. 37.↵
    1. Voth D

    . Das architektonische prinzip der magearterien in seiner bedeutung fur die magenblutung. Zentralbl Allg Pathol. 1962;103:553-554.

    OpenUrl
38. 38.↵
    1. Ma CK,
    2. Padda H,
    3. Pace EH,
    4. Szilagyi E

    . Submucosal arterial malformation of the colon with massive hemorrhage. Report of a case. Dis Colon Rectum. 1989 Feb;32(2):149-152. doi: 10.1007/BF02553829.

    OpenUrlCrossRefPubMed
39. 39.
    1. Barbier P,
    2. Luder P,
    3. Triller J,
    4. Ruchti C,
    5. Hassler H,
    6. Stafford A

    . Colonic hemorrhage from a solitary minute ulcer. Report of three cases. Gastroenterology. 1985 Apr;88(4):1065-1068. doi: 10.1016/s0016-5085(85)80030-5.

    OpenUrlCrossRef
40. 40.
    1. Fockens P,
    2. Tytgat GN

    . Dieulafoy's disease. Gastrointest Endosc Clin N Am. 1996 Oct;6(4):739-752.

    OpenUrlPubMed
41. 41.↵
    1. Mikó TL,
    2. Thomázy VA

    . The caliber persistent artery of the stomach: a unifying approach to gastric aneurysm, Dieulafoy's lesion, and submucosal arterial malformation. Hum Pathol. 1988 Aug;19(8):914-921. doi: 10.1016/s0046-8177(88)80006-6.

    OpenUrlCrossRefPubMedWeb of Science